Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 283Dermatologic 142Tumor-Agnostic 99Gastrointestinal 84Thoracic 82Gynecologic 40Genitourinary 35Sarcoma 28Breast 20Lymphoid 12CNS 10Endocrine 4Other solid neoplasm 3Other 3Plasma cell 2Other neoplasm 2Myeloid 2Other hematologic neoplasm 1NET 1Classical hematology 1

Conditions

Neuroendocrine Tumors 532Gastro-enteropancreatic neuroendocrine tumor 58Carcinoid Tumor 58Neoplasms 49Carcinoma, Neuroendocrine 44Pancreatic Neoplasms 36Adenoma, Islet Cell 33Neoplasm Metastasis 28Pheochromocytoma 26Paraganglioma 24Colorectal Neoplasms 24Stomach Neoplasms 21Breast Neoplasms 21Prostatic Neoplasms 20Lung Neoplasms 20Carcinoma, Hepatocellular 20Sarcoma 19Carcinoma 19Thyroid Neoplasms 18Gastrointestinal Neoplasms 18Neuroblastoma 15Cholangiocarcinoma 14Carcinoma, Renal Cell 14Small Cell Lung Carcinoma 13Melanoma 13Esophageal Neoplasms 13Serotonin Syndrome 12Colonic Neoplasms 12Brain Neoplasms 11Adenocarcinoma 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Squamous Cell × NET × Clear all
NCT04889742 2023-12-26

HETERERO

Charite University, Berlin, Germany

Phase 2 Not yet recruiting
110 enrolled
EndocrineGastrointestinalGenitourinaryGynecologicNETSarcoma

Hyperthermia, Anus Neoplasms, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Fever, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Recurrence, Sarcoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡